$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
利妥昔单抗美罗华一盒多少支?美罗华多少钱一盒?
2025-10-19 11:44:20
Check Details
普乐沙福治疗淋巴瘤效果好吗?有哪些副作用?
2025-10-19 11:44:20
Check Details
释倍灵/普乐沙福药理作用是什么?普乐沙福怎么使用?
2025-10-19 11:44:20
Check Details
抗癌新药普乐沙福是医保报销药吗?你知道吗?
2025-10-19 11:44:20
Check Details
利妥昔单抗多少钱一支?利妥昔单抗纳入医保了吗?
2025-10-19 11:44:20
Check Details
利妥昔单抗报销后一针多少钱?利妥昔单抗报销规则是什么?
2025-10-19 11:44:20
Check Details
打完美罗华要注意什么事项?美罗华有哪些饮食禁忌?
2025-10-19 11:44:20
Check Details
依鲁替尼联合维奈托克一线治疗CLL/SLL具有良好疗效
2025-10-19 11:44:20
Check Details
用药必读!阿卡替尼的中文说明书!
2025-10-19 11:44:20
Check Details
Naratuximab Emtansine+利妥昔单抗治疗弥漫性大B细胞淋巴瘤时疗效持久
2025-10-19 11:44:20
Check Details
CT-P10治疗弥漫性大B细胞淋巴瘤与利妥昔单抗相当
2025-10-19 11:44:20
Check Details
【药物对比】门冬酰胺酶和培门冬有什么不同?
2025-10-19 11:44:20
Check Details
1
2
...
1265
1266
1267
1268
1269
1270
1271
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
2
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
3
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
4
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
5
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
6
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
7
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
8
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
9
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
10
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
11
Pemigatinib for FGFR2-Rearranged Cholangiocarcinoma: Eligibility, Response Limits, Hyperphosphatemia and Ocular Monitoring
12
Cabozantinib with Aspirin: Additive Bleeding Risk, Do Not Stop Cardiac Aspirin Alone, Urgent Warning Signs